Substantia nigra neuromelanin: Structure, synthesis, and molecular behaviour

Journal of Clinical Pathology - Molecular Pathology

Volumn 54, Issue 6, 2001, Pages 414-418

  Zecca, L ^a   Tampellini, D ^a   Gerlach, M ^b   Riederer, P ^b   Fariello, R G ^c   Sulzer, D ^d  

^a INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c Newron Pharmaceuticals   (Italy)

^d Columbia University ^*  (United States)

Author keywords

Locus coeruleus; Neuromelanin; Parkinson's disease; Substantia nigra

Indexed keywords

CATECHOL DERIVATIVE; IRON; LIPID; LIPOFUSCIN; METHYLPHENYLPYRIDINE; NEUROMELANIN; NEUROTOXIN; PESTICIDE; PICOLINE DERIVATIVE; UNCLASSIFIED DRUG;

AGING; BIOACCUMULATION; BRAIN PROTECTION; CELL GRANULE; CELL LEVEL; CELL MEMBRANE; DISEASE ASSOCIATION; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; IRON CHELATION; MAMMAL; MOLECULAR BIOLOGY; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PIGMENTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SUBSTANTIA NIGRA;

AGING; ANIMALS; CELL DEATH; CHELATING AGENTS; CHOLESTEROL; HUMANS; IRON; LIPID METABOLISM; LOCUS COERULEUS; MELANINS; PARAQUAT; PARKINSON DISEASE; PESTICIDES; SUBSTANTIA NIGRA; TOXINS, BIOLOGICAL;

EID: 0035662768     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Melanin pigmentation of the substantia nigra in primates
2. Melanogenesis and extrapiramidal disorders
3. On the origin and significance of neuromelanin
4. Interaction of neuromelanin and iron in substantia nigra and other areas of human brain
5. Melanin pigment in the central nervous system of vertebrates
6. Pigmentation in the nucleus substantiae nigrae of mammals
7. A spectroscopy study of the equine brain melanins
8. Biochemistry of neuromelanin
9. Histochemical relationship and nature of neuromelanin
10. On the nature of pigment granules in the cell of the locus coeruleus and substantia nigra
11. Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus coeruleus in Parkinson's disease
12. Light and electron microscopic studies of pigment in human and rhesus monkey substantia nigra and locus coeruleus
13. Electron microscopic studies on pigment granules in the substantia nigra and locus coeruleus of the Japanese monkey (macaca fuscata yukui)
14. The histochemical relationship of neuromelanin and lipofuscin
15. Neuromelanin in the substantia nigra of adult horses
16. Lipoprotein pigments - Their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells
17. A brainstem atlas of catecholaminergic neurons in man, using melanin as natural marker
18. The melanoneurons of the human cerebellum (nucleus pigmentosus cerebellaris) and homologues in the monkey
19. Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?
20. Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease
21. Biochemical pathophysiology of Parkinson's disease
22. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations
23. Purified human neuromelanin, synthetic dopamine melanin as a potential model pigment, and the normal human substantia nigra: Characterization by electron paramagnetic resonance spectroscopy
24. Total and paramagnetic metals in human substantia nigra and its neuromelanin
25. Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain
26. The neuromelanin of substantia nigra
27. Neuromelanin of the human substantia nigra: A mixed type melanin
28. The chemical characterization of melanin contained in substantia nigra of human brain
29. The structure of neuromelanin and its iron binding site studied by infrared spectroscopy
30. Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins
31. The interaction of human substantia nigra neuromelanin with lipids and peptides
32. Detection of 5-S-cysteinyldopamine in human brain
33. On the function of neuromelanin
34. Cysteinyldopamine is not incorporated into neuromelanin
35. X-ray characterization of melanins - II
36. Structure of human neuromelanin by X-ray diffraction: Comparison with synthetics
37. Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles
38. Tyrosinase: A review of its mechanism
39. Tyrosinase mRNA is expressed in human substantia nigra
40. New evidence for presence of tyrosinase in substantia nigra, forebrain, and midbrain
41. Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra?
42. Generation of reactive oxygen species by tyrosine hydroxylase: A possible contribution to the degeneration of dopaminergic neurons
43. The role of peroxidase in neuromelanin synthesis: A review
44. Prostaglandin H synthetase-mediated metabolism of dopamine: Implication for Parkinson's disease
45. Enzymatic oxidation of dopamine: The role of prostaglandin H synthase
46. Enzyme activity of macrophage migration inhibitory factor toward oxidized catecholamines
47. Occurrence and distribution of 5-S-cysteinyl derivates of dopamine, dopa and dopac in brains of eight mammalian species
48. Chronic parkinsonism in humans due to product of meperedineanalog synthesis
49. Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,5-tetrahydropiridine
50. Biochemical of 1-methyl-4-phenyl-1,2,3,5-tetrahydropyridine toxicity: Could oxidative stress be involved in the brain?
51. MPTP: Current concepts and controversies
52. Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man
53. Selectivity of the parkinsonian neurotoxin MPTP: Toxic metabolite MPP+ binds to neuromelanin
54. 14C]diquat in frogs and mice: Accumulation in neuromelanin
55. Binding of dopaminergic drugs by the neuromelanin of the substantia nigra, synthetic melanins and melanin granules
56. Evidence for a glicidic-lipidic matrix in human neuromelanin, potentially responsible for the enhanced iron sequestering ability of substantia nigra
57. Iron, neuromelanin and ferritin in substantia nigra of normal subjects at different ages. Consequences for iron storage neurodegenerative disorders
58. Trace element concentration in human brain
59. Brain trace element in aging
60. Modulation by neuromelanin of the availability and reactivity of metal ions
61. Mössbauer spectroscopic studies of human neuromelanin isolated from the substantia nigra
62. Increased nigral iron content and alteration in other metal ions occurring in brain in Parkinson's disease
63. Selective increase of iron in substantia nigra zone compacta of parkinsonian brain
64. Neuromelanin containing neurons of the substantia nigra accumulate iron and aluminium in Parkinson's disease: A LAMMA study
65. Iron-melanin complex in substantia nigra of parkinsonian. Brains: An X-ray microanalysis
66. Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: An electron paramagnetic resonance spectroscopy study
67. Iron in parkinsonian and control substantia nigra, a Mossbauer spectroscopy study
68. X-ray absorption fine-structure spectroscopy studies of Fe sites in natural human neuromelanin and synthetic analogues
69. The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems
70. Studies on neuromelanin. I. A melanin system in the human adult brainstem
71. Neuromelanic pigment in substantia nigra neurons of rats and dogs
72. Studies on neuromelanin. II. Melanin in the brainstems of infants and children
73. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method
74. Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India
75. Preservation of midbrain catecholaminergic neurons in very old human subjects
76. Aging and extrapyramidal functions
77. The anatomy of the human substantia nigra in relation to selective neuronal vulnerability
78. Possible role of neuromelanin in the pathogenesis of Parkinson's disease
79. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer disease brains
80. Evidence of active nerve cell degeneration in the substantia nigra of human years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure
81. The roles of neuromelanin binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: A hypothesis